Sagent Pharmaceuticals

Sagent Pharmaceuticals is a privately held specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectable products. Sagent has created a unique, global network of resources, comprised of rapid development capabilities, sophisticated manufacturing and innovative drug-delivery technologies, quickly yielding an extensive portfolio of pharmaceutical products that fulfills the evolving needs of patients. Sagent currently has more than 200 products in development.

Type
Public
HQ
Schaumburg, US
Founded
2006
Employees
440 (est)+250%
Sagent Pharmaceuticals was founded in 2006 and is headquartered in Schaumburg, US

Sagent Pharmaceuticals Locations

Schaumburg, US

Sagent Pharmaceuticals Metrics

Sagent Pharmaceuticals Summary

Market capitalization

$716 M

Closing share price

$21.8
Sagent Pharmaceuticals's current market capitalization is $716 M.

Sagent Pharmaceuticals Financials

Sagent Pharmaceuticals's revenue is $318 M in FY, 2015 which is 10.14% increase from the previous period.
FY, 2013FY, 2014FY, 2015

Revenue

$245 M$289 M$318 M

Gross profit

$77.5 M$86.2 M$87.7 M

Operating income

$29 M$15.1 M$-47.1 M

Operating expense total

$54.1 M$67.1 M$84.7 M

Net Income

$29.6 M$39.9 M$-21.9 M

Operating cash flow

$14.6 M$13.3 M$-26.7 M

    Sagent Pharmaceuticals News

    Sagent Pharmaceuticals Company Life

    You may also be interested in